Loring/Campbell article in 311 Science 1716 (2006)
The article points out that there are four more applications claiming priority to the parent case:
09/982,637
10/430,496
11/033,335
11/036,245
The article raises the possibility of an interference with patents issued to Plurion, US 5,690,926 and US 5,670,372.
Although Campbell was involved in the Merck v. Integra case, the Science article does not mention the possibility that research on stem cells, the ultimate product of which would require FDA approval, might be insulated from infringement under 35 USC 271(e)(1). The article also does not mention Florida Prepaid Postsecondary.
0 Comments:
Post a Comment
<< Home